This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Frédéric Le Moal | |
|---|---|
| Name | Frédéric Le Moal |
| Nationality | French |
| Occupation | Neuroscientist, Professor |
| Known for | Research on addiction, neuroplasticity, dopamine systems |
Frédéric Le Moal is a French neuroscientist and academic known for work on addiction, neurobiology of reward, and stress-related neuroplasticity. He has held positions at institutions associated with neuroscience research and has published extensively on mechanisms of drug dependence, synaptic plasticity, and behavioral neuroscience. His research intersects with pharmacology, psychiatry, and behavioral sciences.
Le Moal was educated in France, completing advanced study and doctoral training within institutions linked to Inserm, Université Paris-Sud, and research networks connected to Collège de France and CNRS. During his formative years he trained in laboratories engaged with investigators tied to Pierre Changeux, Jean-Pierre Changeux, Michel Le Moal—with whom he collaborated on themes of reward and addiction—and networks including researchers from INSERM UMR units, École Normale Supérieure, and European centers such as Karolinska Institutet and University College London. His doctoral and postdoctoral mentors included figures active in neuropharmacology and behavioral neuroscience, aligning him with programs funded by agencies like ANR and the European Research Council.
Le Moal's academic career spans appointments at French universities and research institutes where he directed laboratories studying the neurobiology of addiction, stress, and motivation. He collaborated with investigators at Institut du Cerveau et de la Moelle Épinière, Centre Hospitalier Universitaire de Bordeaux, and international partners at Harvard Medical School, Yale School of Medicine, and Max Planck Society laboratories. His work integrated techniques from electrophysiology pioneered in groups at Salk Institute, molecular approaches associated with INSERM teams, and behavioral paradigms developed in laboratories linked to National Institute on Drug Abuse and Institut Pasteur. He participated in consortia with Wellcome Trust-funded projects and contributed to curriculum and doctoral training programs at Université Paris Descartes and Sorbonne Université.
Le Moal's contributions include empirical and theoretical advances on the role of the mesolimbic dopamine system in drug reinforcement, interactions between stress circuits and addictive behaviors, and mechanisms of synaptic plasticity underlying relapse. He published articles addressing dopamine signaling studied relative to ventral tegmental area, nucleus accumbens, and prefrontal networks implicated in reward prediction error models developed by groups around Wolfram Schultz and computational frameworks inspired by Reinforcement learning. His collaborations yielded studies on glutamatergic transmission, long-term potentiation, and long-term depression relevant to work from laboratories at Cold Spring Harbor Laboratory and Beth Israel Deaconess Medical Center. Le Moal coauthored reviews synthesizing findings for audiences of Nature Reviews Neuroscience, Neuron, and The Journal of Neuroscience readers, and contributed chapters in volumes published by Oxford University Press and Cambridge University Press. Selected topics covered include pharmacological modulation with compounds linked to methamphetamine, cocaine, alcohol use disorder models, and interactions with stress hormones such as corticosterone studied alongside research from National Institute of Mental Health investigators.
Throughout his career, Le Moal received recognition from French and international bodies including prizes from Inserm-affiliated foundations, awards connected to the Société de Neurosciences, and distinctions associated with universities such as Université de Bordeaux and national research councils like CNRS. He was invited to deliver keynote lectures at symposia hosted by organizations such as Society for Neuroscience, European College of Neuropsychopharmacology, and International Society for Neurochemistry, and served on advisory panels for funding agencies including the European Commission and the French Ministry of Higher Education, Research and Innovation.
Le Moal has been affiliated with professional societies including the Society for Neuroscience, European Brain and Behaviour Society, and the French Neuroscience Society. He collaborated with clinicians and researchers from Hôpital Sainte-Anne, Pitié-Salpêtrière Hospital, and multidisciplinary teams spanning psychiatry departments at major teaching hospitals. Outside research, he engaged in science communication and academic mentorship through programs at institutions like École Polytechnique and European doctoral networks such as Marie Skłodowska-Curie Actions.
Category:French neuroscientists Category:Neuropharmacologists